Navigation Links
AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results
Date:3/11/2009

31 535 868 1,904 1,441 Interest expense (50) (23) (118) (85) (1,433) Foreign exchange gain (loss) 2,642 (269) 3,071 (1,035) 319 Other 46 (27) (79) (28) 409 ------------------------------------------------------------------------- 2,769 216 3,742 756 736 ------------------------------------------------------------------------- Share in the results of an affiliated company - - - - 1,575 ------------------------------------------------------------------------- Loss before income taxes from continuing operations (13,546) (11,448) (58,642) (33,998) (21,460) Income tax (expense) recovery (947) (2,406) (1,175) 1,961 29,037 ------------------------------------------------------------------------- Net (loss) earnings from continuing operations (14,493) (13,854) (59,817) (32,037) 7,577 Net (loss) earnings from discontinued operations - 218 - (259) 25,813 ------------------------------------------------------------------------- Net (loss) earnings for the period (14,493) (13,636) (59,817) (32,296) 33,390 ------------------------------------------------------------------------- ------------------------------------------------------------------------- Net (loss) earnings per share from continuing operations Basic (0.27) (0.26) (1.12) (0.61) 0.14 Diluted (0.27) (0.26) (1.12) (0.61) 0.14 Net (loss) earnings per share from discontinued operations Basic - - - - 0.50 Diluted - - - -
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015  ArroGen Group, an ... new Fingerprint Molecular Identification™ (FMID) technology Aug. 2-8 ... in Sacramento, Calif. ... will enable law enforcement agents, district attorneys and ... criminal suspects. By analyzing chemical residues ...
(Date:8/3/2015)... Ga. , Aug. 3, 2015  MiMedx Group, ... company utilizing human amniotic tissue and patent-protected processes to ... Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... present at the 35 th Annual Canaccord|Genuity Growth ... H. "Pete" Petit, Chairman and CEO, William C. ...
(Date:8/3/2015)... Aug. 3, 2015  Merck KGaA, Darmstadt, ... top-quality high-tech products in the healthcare, life science and ... company Nano-C, their development and launch of promising new ... (OPV). Merck KGaA, Darmstadt, Germany , ... OPV sector. Novel derivatives: highly stable, easy ...
(Date:8/3/2015)... Medical, Inc. (Nasdaq: AEMD ), the pioneer in ... announced that it will host its First Quarter Fiscal ... 13, 2015 at 4:30 p.m. Eastern Time. ... fiscal 2016 first quarter results.  A recorded version of ... the call at the Investor Relations portion of the ...
Breaking Biology Technology:ArroGen Previews New Fingerprint Molecular Identification Technology 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2
... , ... , , , Quantitative ... procedure in many laboratories.,Protocols are available for various applications,especially in ... division by exogenous factors,stimulation/inhibition by cytokines, development of,serum-free media, influence ...
... , , , ... , , , , ... the first companies,to offer a nonradioactive technology allowing customers,to move away ... the,increasing availability of many different competitor,products and quantitative PCR-based technologies, the,DIG ...
... , , ... , , , Since the ... of foreign genes,appeared a few years ago, RNAi has become a ... short double-stranded RNAs that are,homologous to the suppressed gene. These small ...
Cached Biology Technology:Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 2Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 3Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 4Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 5Quantitative Measurement of Cell Proliferation,Using the BrdU ELISA: A Comparison,Between Colorimetric and Chemiluminescent Detection 6The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 2The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 3The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 4The DIG System Nonradioactive and,Highly Sensitive Detection of Nucleic Acids 5Quantification of siRNA Silencing Efficiency,Using the LightCycler System 2Quantification of siRNA Silencing Efficiency,Using the LightCycler System 3Quantification of siRNA Silencing Efficiency,Using the LightCycler System 4Quantification of siRNA Silencing Efficiency,Using the LightCycler System 5
(Date:8/4/2015)... Aug. 4, 2015  AMRI (NASDAQ: AMRI ) today reported ... 2015. Highlights: , Second quarter contract revenue ... 2014 , Adjusted contract margins of ... $0.22, including a $0.05 decrease in EPS from royalties in the ... million "We are very pleased to present another ...
(Date:7/31/2015)... China , 31 de julho de 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) será realizada pela BGI de 22-25 ... . A conferência está celebrando seu ... em 2006, a ICG se tornou uma das reuniões ... um dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND SYSTEM ... crypto-currencies such as Bitcoin into the consumer market of ... manage all payments.  The technology manages ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... involved in many forms of leukemia and lymphoma is ... our genes by affecting whole swaths of chromosomes in ... issue of Nature Genetics and appearing online August 6. ... known as JAK/STAT focused on complex questions involving the ...
... Somerville of the Carnegie Institution and Stanford University, explained ... and achievable to reduce costs and multiply current levels ... Somerville presented his talk, "Bioenergy: The 21st Century Challenge ... American Society of Plant Biologists (ASPB) today (4:30 p.m. ...
... is a particular place inside a cell where they carry ... from the Charité Berlin, the University of Heidelberg, and the ... been able to visualize the structure of a "molecular machine" ... analysis. , This "machine" is made up of a ...
Cached Biology News:Loosen up, DNA: Leukemia gene changes genetic packaging 2Loosen up, DNA: Leukemia gene changes genetic packaging 3Loosen up, DNA: Leukemia gene changes genetic packaging 4Scientific issues associated with carbon-neutral energy sources such as cellulosic ethanol 2The molecular post office inside the cell 2
... series embodies all aspects of classical microscopy ... powerful Achromatic Super Contrast (ASC) objectives coupled ... this microscope combines flexibility and professional microscopy ... B1 series, the DM-B1 steps into the ...
... gel stain is a sensitive nucleic ... when bound to RNA and low background ... with either formaldehyde/agarose or polyacrylamide gels using ... 500 µL unit size (S-7564) and 1mL ...
... and reports the data from any one of ... chart recorder. The final data is sent from ... selection is automatic for Systolic, Mean, Heart Rate ... user is always in the position to override ...
... HT is taking automated patch clamping to a ... ability to generate thousands of high quality data ... paradigms in ion channel drug discovery and safety ... quality afforded by conventional patch clamping can now ...
Biology Products: